EpileaseEpilease, an anti-epileptic therapy product, is back on the market following official licensing from the VMD.

The product comes from veterinary nutraceutical expert VetPlus and contains potassium bromide, a well-established adjunctive treatment for epilepsy in dogs.

VetPlus halted the mass circulation of the product in 2011, but has now reintroduced Epilease 250mg, with the same formulation, in a blister pack of 60 capsules.


Phillipa Lomax, senior marketing manager at VetPlus, said: “Epilease is a trusted treatment for thousands of dog owners worldwide, so we are pleased to announce it is back on the market.

“We are now able to offer another treatment option, thereby improving not only seizure management in canine patients, but also aiding dogs’ and owners’ quality of life.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

Ian Ramsey, Susanna Spence and Emma Roberts having all been involved in a desoxycortone pivalate clinical trial, provide a review of hypoadrenocorticism, as well as suggestions for management in dogs.

29 mins

Interpreting effusion samples can be confusing, says Gerardo Poli, so try to think of them as if you were collecting a blood sample.

4 mins

James Oxley and Tamara Montrose take a look at several cases and research studies into the causes and factors related to cats falling from tall structures, and the resulting injuries sustained.

11 mins

Sebastien Behr looks at signs, diagnosis and treatment of masses found in the pituitary gland.

7 mins

Andy Durham discusses forms of protection against illnesses in horses, such as tetanus and equine arteritis virus.

20 mins

Zoetis has launched Sileo, a novel oromucosal gel designed to help calm pets suffering noise phobias.

3 mins